Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rexlemestrocel-L in Type 2 Diabetes
NCT01576328Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Apr 2012
- Primary completion
- Oct 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of rexlemestrocel-l in type 2 diabetes mellitus (T2DM), sponsored by Mesoblast Ltd. Started Apr 2012; status: completed.
02
Drugs
rexlemestrocel-l
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01576328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576328.